PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Granisetron Hydrochloride ×

UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Approves Labeling for Granisetron Hydrochloride Tablet (ANDA078080)
FDA approved multiple labeling submissions for Teva's granisetron hydrochloride oral tablet (ANDA078080), which is listed as discontinued.